Results 51 to 60 of about 11,421 (234)

Attitudes of European psychiatrists on psychedelics: a cross-sectional survey study

open access: yesScientific Reports
Research and public interest in psychedelic-assisted psychotherapy (PAP) are growing. This study investigated attitudes toward psychedelics among a diverse and multinational sample of psychiatrists currently working in Europe.
Marija Franka Žuljević   +4 more
doaj   +1 more source

Psychedelics for Moral Bioenhancement in Healthy Individuals—A Violation of the Non-Maleficence Principle?

open access: yesPsychoactives
Several authors have advanced the idea that psychedelics such as psilocybin might be effective means for achieving moral bioenhancement (MBE). Here, I discuss some reservations on this assertion from both neuropharmacological and bioethical perspectives,
Bor Luen Tang
doaj   +1 more source

Psychedelics: A new era of treatment?

open access: yesEuropean Psychiatry, 2021
Introduction Psychedelics - including LSD (lysergic acid diethylamide), psilocybin, DMT (N, N-dimethyltryptamine), ayahuasca and mescaline - have an ancient history across various civilizations.
S. Torres
doaj   +1 more source

Healing together: Results from a pilot trial of 3,4‐Methylenedioxymethamphetamine‐enhanced cognitive‐behavioral conjoint therapy for posttraumatic stress disorder

open access: yesJournal of Traumatic Stress, EarlyView.
Abstract Posttraumatic stress disorder (PTSD) disrupts individual well‐being and relationship health, particularly among veteran/military couples with heightened risks due to deployment, family reintegration, and traumatic stress. Although cognitive‐behavioral conjoint therapy (CBCT) and brief CBCT (bCBCT) have demonstrated strong efficacy in reducing ...
Leslie A. Morland   +11 more
wiley   +1 more source

Guidelines for Meta‐Analytic Structural Equation Modeling: Steps, Resources, and Illustrations

open access: yesPsychology &Marketing, EarlyView.
ABSTRACT The goal of science is to build incremental, structured, and reliable knowledge over time. Yet, many strands of marketing and related disciplines exhibit symptoms of cumulative stagnation, including lack of replicability and weak theoretical integration. Existing remedies such as replication studies, multistudy investigations, and open science
Hassam Waheed, Weng Marc Lim
wiley   +1 more source

Ethical and legal issues in psychedelic harm reduction and integration therapy

open access: yesHarm Reduction Journal, 2021
Psychedelic-assisted therapy may represent an upcoming paradigm shift in the treatment of mental health problems as recent clinical trials have demonstrated strong evidence of their therapeutic benefits.
Brian Pilecki   +4 more
doaj   +1 more source

Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?

open access: yesFrontiers in Psychiatry, 2023
IntroductionCurrent treatment options for major depressive disorder (MDD) have limited efficacy and are associated with adverse effects. Recent studies investigating the antidepressant effect of serotonergic psychedelics—also known as classic ...
Muhammad Ishrat Husain   +12 more
doaj   +1 more source

Longing for nature: Becoming more connected to nature through nostalgia

open access: yesPeople and Nature, EarlyView.
Abstract Repairing the human–nature relationship is one of the century's defining tasks. In this paper, we were interested in whether nature‐based nostalgia was a significant and unique predictor of higher nature connectedness as a key operationalisation of the human–nature relationship.
Michael L. Lengieza, Rosemary Aviste
wiley   +1 more source

Philosophy and psychedelics: Frameworks for exceptional experience [PDF]

open access: yes, 2023
The intersection between philosophy and psychedelics is explored in the book “Philosophy and Psychedelics: Frameworks for Exceptional Experience”. The authors aim to develop a dialogue between the two disciplines and explore the various frameworks for ...
Dowie, Traill, Tempone-Wiltshire, Julien
core   +2 more sources

Well-being as a primary endpoint in clinical trials: a call for consensus

open access: yesnpj Mental Health Research
Psychiatric trials typically define success as symptom reduction, yet patients prioritize meaning, vitality, and functioning. This imbalance undervalues experiential benefits, distorting clinical, policy, and FDA decisions.
Elliot Marseille   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy